Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2016.1138292.
Funding information
This work was funded by the Leukemia and Lymphoma Society of Canada, the Canadian Stem Cell Network, the Canadian Institutes of Health Research (CIHR), the Princess Margaret Cancer Centre Foundation, and the Ministry of Long Term Health and Planning in the Province of Ontario. LER was supported by a CIHR Frederick Banting and Charles Best Canada Graduate Scholarship, CIHR MD/PhD Studentship, Peterborough KM Hunter Graduate Studentship, and Hernandez Family Oncology MD/PhD Fellowship. ADS holds the Baker Chair in Leukemia and Related Diseases.